SecBot SecBot
8-K ·Filed Feb 25, 2026

AGL

agilon health, inc.
MIXED
Impact 6/10
Horizonmonths Processed8mo ago SEC0001628280-26-011630
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

Monitor execution of cost reduction initiatives and medical cost trend management in 2026. The significant improvement in guidance suggests potential turnaround, but investors should watch for actual execution against these ambitious targets.

DirectionMixed
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$0.5946
T+0 close · Feb 25, 2026 · via day close
Latest settled
+481.16%
T+60 · $3.46
Vs SPY
+472.99%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Feb 26 $0.5946entry
  2. T+1 · 9mo ago −0.89%α −0.41% · $0.5893
  3. T+5 · 9mo ago +11.76%α +12.91% · $0.6645
  4. T+20 · 8mo ago −35.96%α −29.54% · $0.3808
  5. T+60 · 6mo ago +481.16%α +472.99% · $3.46
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Agilon Health reported a decline in financial performance for fiscal year 2025, with revenue down 2%, gross loss of $160M, and Adjusted EBITDA loss of $296M. However, the company issued 2026 guidance projecting a return to breakeven Adjusted EBITDA, driven by improved rates, cost discipline, and portfolio optimization. This combination of poor results with optimistic forward guidance creates a mixed outlook.

Key Financial Metrics

Revenue
$5.9B
-2.0% YoY
EPS
$-0.98
Guidance
$5.41B-$5.58B
initiated

Key Facts

  • 2025 revenue decreased 2% YoY to $5.93B
  • Gross loss was $160M in 2025 vs. $5M profit in 2024
  • Adjusted EBITDA loss was $296M in 2025 vs. $154M loss in 2024
  • 2026 guidance projects Adjusted EBITDA breakeven at midpoint
  • Medical margin guidance for 2026 is $300-350M vs. $57M loss in 2025
  • Company reduced operating expenses by $35M for 2026

Financial Impact

2025 revenue down $128M, gross profit down $165M, Adjusted EBITDA loss up $142M; 2026 guidance projects breakeven Adjusted EBITDA

revenuegrossProfitadjustedEBITDAmedicalMargin

Segment Breakdown

SegmentRevenue
Medicare Advantage$5.9B
ACO Model$1.7B

Risk Factors

  • Failure to achieve projected breakeven Adjusted EBITDA in 2026
  • Continued elevated medical cost trends at 7.5% gross
  • Execution risk on portfolio optimization and cost reduction initiatives

Market Snapshot

Exchange
NYSE

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-011630
Exhibit: ex-9922025q4.htm0001628280-26-011630
Document: agl-20260225.htm0001628280-26-011630
Document: 0001628280-26-011630-index-headers.html0001628280-26-011630
Document: 0001628280-26-011630-index.html0001628280-26-011630
Document: 0001628280-26-011630.txt0001628280-26-011630

Track record

7 reports on AGL

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today Institutional Cluster Mixed 3/10 Entry $117.09 Now $116.75 −0.29% settles Nov 23
  2. Nov 10, 20266d ago Institutional Cluster Neutral 3/10 Entry $113.52 Now $116.75 +2.85% settles Nov 17
  3. Nov 4, 202612d ago 8-K Bullish 7/10 Entry $113.77 to $110.30 Now $116.75 +2.62% ▼ −3.05% −6.34% vs SPY
  4. Apr 27, 202629w ago DEFA14A Neutral 2/10 Entry $27.90 to $26.94 Now $116.75 +318.46% ▼ −3.44% −5.13% vs SPY
  5. Apr 27, 202629w ago 8-K Neutral 4/10 Entry $27.90 to $26.94 Now $116.75 +318.46% ▼ −3.44% −5.13% vs SPY
  6. Feb 28, 202637w ago Institutional Cluster Bullish 6/10 Entry $15.40 to $15.00 Now $116.75 +658.12% ▼ −2.60% −1.42% vs SPY
  7. Feb 25, 202637w ago 8-K Mixed 6/10 Viewing Entry $0.5946 to $0.6645 Now $116.75 +19535.05% ▲ +11.76% +12.91% vs SPY
Showing 7 of 7

US Market Status

Market Closed · Opens in 7h 18m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 25, 2026